FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1983663048> ?p ?o ?g. }

• W1983663048 endingPage "1776" @default.
• W1983663048 startingPage "1770" @default.
• W1983663048 abstract "In the REAL classification the diffuse large B-cell non-Hodgkin lymphomas (NHL) are grouped together, because subclassifications are considered to lack both reproducibility and clinical significance. Others, however, claim that patients with an immunoblastic NHL have a worse prognosis than patients with other types of diffuse large B-cell NHL. Therefore, we investigated the prognostic and clinical significance of histological subclassification of diffuse large B-cell NHL in a uniformly treated series of patients. For this retrospective study, all patients diagnosed as having an immunoblastic (IB) B-cell NHL by the Lymphoma Review Panel of the Comprehensive Cancer Center Amsterdam (CCCA) between 1984 and 1994, and treated according to the guidelines of the CCCA, were analysed. Patients with a centroblastic polymorphic subtype (CB-Poly) or centroblastic (CB) NHL by the Lymphoma Review Panel who were treated in the Netherlands Cancer Institute during the same period according to CCCA guidelines were used as reference groups. All patients' records were reviewed. Clinical parameters at presentation, kind of therapy and clinical outcome were recorded. All available histological slides were separately reviewed by two haemato-pathologists. One hundred and seventy-seven patients were included in the study: 36 patients (20.3%) with an IB NHL, 69 patients (39%) with a CB-Poly NHL and 72 patients (40.7%) with a CB NHL. The patients with an IB NHL tended to be older and presented more often with stage I or II and one extranodal site than patients with a CB and CB-Poly NHL. None of the subtypes showed a clear preference for localization in a particular site. The patients with IB or CB-Poly NHL showed a significantly worse prognosis than patients with CB NHL, with a 5-year overall survival for patients with CB NHL of 56.3% and for patients with IB or CB-Poly NHL 39.1% and 41.6% respectively. The 5-year disease free survival was 53.2% for the patients with CB, 32% for the patients with CB-Poly and 26.9% for the patients with IB NHL. A multivariate analysis showed that histological subtyping was of prognostic significance independent of the International Prognostic Index. This finding merits further exploration in prospective studies in order to judge the value of subclassification of large B-cell NHL as a guideline in therapy choice." @default.
• W1983663048 created "2016-06-24" @default.
• W1983663048 creator A5001539044 @default.
• W1983663048 creator A5009172923 @default.
• W1983663048 creator A5040921984 @default.
• W1983663048 creator A5052270517 @default.
• W1983663048 creator A5053418510 @default.
• W1983663048 creator A5063335991 @default.
• W1983663048 creator A5079653529 @default.
• W1983663048 creator A5082130339 @default.
• W1983663048 creator A5083240466 @default.
• W1983663048 date "1999-03-12" @default.
• W1983663048 modified "2023-10-12" @default.
• W1983663048 title "Diffuse large B-cell non-Hodgkin lymphomas: the clinical relevance of histological subclassification" @default.
• W1983663048 cites W1867200418 @default.
• W1983663048 cites W1957147688 @default.
• W1983663048 cites W1991787503 @default.
• W1983663048 cites W2031148304 @default.
• W1983663048 cites W2055282731 @default.
• W1983663048 cites W2071068441 @default.
• W1983663048 cites W2097467509 @default.
• W1983663048 cites W2107202569 @default.
• W1983663048 cites W2114536023 @default.
• W1983663048 cites W2125114406 @default.
• W1983663048 cites W2138938132 @default.
• W1983663048 cites W2260279798 @default.
• W1983663048 cites W2328393644 @default.
• W1983663048 cites W2418256349 @default.
• W1983663048 cites W2474591869 @default.
• W1983663048 cites W4205736005 @default.
• W1983663048 cites W4252168887 @default.
• W1983663048 doi "https://doi.org/10.1038/sj.bjc.6690282" @default.
• W1983663048 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2362805" @default.
• W1983663048 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10206291" @default.
• W1983663048 hasPublicationYear "1999" @default.
• W1983663048 type Work @default.
• W1983663048 sameAs 1983663048 @default.
• W1983663048 citedByCount "25" @default.
• W1983663048 countsByYear W19836630482012 @default.
• W1983663048 countsByYear W19836630482016 @default.
• W1983663048 countsByYear W19836630482020 @default.
• W1983663048 countsByYear W19836630482021 @default.
• W1983663048 crossrefType "journal-article" @default.
• W1983663048 hasAuthorship W1983663048A5001539044 @default.
• W1983663048 hasAuthorship W1983663048A5009172923 @default.
• W1983663048 hasAuthorship W1983663048A5040921984 @default.
• W1983663048 hasAuthorship W1983663048A5052270517 @default.
• W1983663048 hasAuthorship W1983663048A5053418510 @default.
• W1983663048 hasAuthorship W1983663048A5063335991 @default.
• W1983663048 hasAuthorship W1983663048A5079653529 @default.
• W1983663048 hasAuthorship W1983663048A5082130339 @default.
• W1983663048 hasAuthorship W1983663048A5083240466 @default.
• W1983663048 hasBestOaLocation W19836630481 @default.
• W1983663048 hasConcept C121608353 @default.
• W1983663048 hasConcept C126322002 @default.
• W1983663048 hasConcept C142724271 @default.
• W1983663048 hasConcept C143998085 @default.
• W1983663048 hasConcept C146357865 @default.
• W1983663048 hasConcept C151730666 @default.
• W1983663048 hasConcept C167135981 @default.
• W1983663048 hasConcept C2778476748 @default.
• W1983663048 hasConcept C2778559949 @default.
• W1983663048 hasConcept C2779338263 @default.
• W1983663048 hasConcept C2780039790 @default.
• W1983663048 hasConcept C63363279 @default.
• W1983663048 hasConcept C71924100 @default.
• W1983663048 hasConcept C86803240 @default.
• W1983663048 hasConcept C90924648 @default.
• W1983663048 hasConceptScore W1983663048C121608353 @default.
• W1983663048 hasConceptScore W1983663048C126322002 @default.
• W1983663048 hasConceptScore W1983663048C142724271 @default.
• W1983663048 hasConceptScore W1983663048C143998085 @default.
• W1983663048 hasConceptScore W1983663048C146357865 @default.
• W1983663048 hasConceptScore W1983663048C151730666 @default.
• W1983663048 hasConceptScore W1983663048C167135981 @default.
• W1983663048 hasConceptScore W1983663048C2778476748 @default.
• W1983663048 hasConceptScore W1983663048C2778559949 @default.
• W1983663048 hasConceptScore W1983663048C2779338263 @default.
• W1983663048 hasConceptScore W1983663048C2780039790 @default.
• W1983663048 hasConceptScore W1983663048C63363279 @default.
• W1983663048 hasConceptScore W1983663048C71924100 @default.
• W1983663048 hasConceptScore W1983663048C86803240 @default.
• W1983663048 hasConceptScore W1983663048C90924648 @default.
• W1983663048 hasIssue "11-12" @default.
• W1983663048 hasLocation W19836630481 @default.
• W1983663048 hasLocation W19836630482 @default.
• W1983663048 hasLocation W19836630483 @default.
• W1983663048 hasLocation W19836630484 @default.
• W1983663048 hasOpenAccess W1983663048 @default.
• W1983663048 hasPrimaryLocation W19836630481 @default.
• W1983663048 hasRelatedWork W126334582 @default.
• W1983663048 hasRelatedWork W1984553778 @default.
• W1983663048 hasRelatedWork W2026342042 @default.
• W1983663048 hasRelatedWork W2137702207 @default.
• W1983663048 hasRelatedWork W2184806759 @default.
• W1983663048 hasRelatedWork W2395997009 @default.
• W1983663048 hasRelatedWork W2407970965 @default.
• W1983663048 hasRelatedWork W2806991430 @default.

• next